Sara Zaknoen
Director/Miembro de la Junta en ATYR PHARMA, INC. .
Fortuna: 9 570 $ al 30/04/2024
Perfil
Dr. Sara L.
Zaknoen, MD, is an Independent Director at aTyr Pharma, Inc. She is on the Board of Directors at aTyr Pharma, Inc. Dr. Zaknoen was previously employed as a Chief Medical Officer by Ignyta, Inc., a Chief Medical Officer by Tragara Pharmaceuticals, Inc., a Director-Clinical Oncology Research by Schering-Plough Research Institute, a Chief Medical Officer by Cabrellis Pharmaceuticals Corp., an Executive Director-Clinical Oncology Research by Novartis Pharmaceuticals Corp., a Chief Medical Officer by Polynoma LLC, a Director-Experimental Therapeutics by The Western Pennsylvania Hospital, and a Medical Director by University of Cincinnati (Ohio).
She received her undergraduate degree from Valparaiso University and a doctorate degree from Indiana University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ATYR PHARMA, INC.
0.01% | 01/03/2024 | 6 000 ( 0.01% ) | 9 570 $ | 30/04/2024 |
Cargos activos de Sara Zaknoen
| Empresas | Cargo | Inicio |
|---|---|---|
| ATYR PHARMA, INC. | Director/Miembro de la Junta | 25/05/2021 |
Antiguos cargos conocidos de Sara Zaknoen.
| Empresas | Cargo | Fin |
|---|---|---|
| IGNYTA INC | Director Técnico/Científico/I+D | 28/04/2014 |
Adastra Pharmaceuticals, Inc.
 Adastra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Adastra Pharmaceuticals, Inc. engages in the provision of clinical and commercial development of proprietary drugs for the treatment of various cancers. The company was founded by Tracy L. Parrott in 2005 and is headquartered in Princeton, NJ. | Director Técnico/Científico/I+D | - |
Cabrellis Pharmaceuticals Corp.
 Cabrellis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Cabrellis Pharmaceuticals Corp. manufactures medical products. The firm develops therapies for treatment of cancer. The company was founded by Thomas M. Estok, Lawrence C. Fritz and Christopher C. LeMasters in 2006 and is headquartered in Summit, NJ. | Director Técnico/Científico/I+D | - |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Corporate Officer/Principal | 02/01/2002 |
Polynoma LLC
 Polynoma LLC BiotechnologyHealth Technology Part of CK Life Sciences International (Holdings), Inc., Polynoma LLC is an immuno-oncology focused biopharmaceutical company headquartered in San Diego, CA. Polynoma's lead asset is a novel polyvalent antigen vaccine, Seviprotimut-L, for the prevention of recurrence of melanoma. The vaccine has been safely administered in more than 1,000 patients. Polynoma is an immuno-oncology company developing a novel polyvalent antigen therapy for the treatment of melanoma. The company was founded by Paul A. Hopper. | Director Técnico/Científico/I+D | - |
Formación de Sara Zaknoen.
| Indiana University | Doctorate Degree |
| Valparaiso University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| Empresas privadas | 7 |
|---|---|
Adastra Pharmaceuticals, Inc.
Adastra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Adastra Pharmaceuticals, Inc. engages in the provision of clinical and commercial development of proprietary drugs for the treatment of various cancers. The company was founded by Tracy L. Parrott in 2005 and is headquartered in Princeton, NJ. | Health Technology |
Cabrellis Pharmaceuticals Corp.
Cabrellis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Cabrellis Pharmaceuticals Corp. manufactures medical products. The firm develops therapies for treatment of cancer. The company was founded by Thomas M. Estok, Lawrence C. Fritz and Christopher C. LeMasters in 2006 and is headquartered in Summit, NJ. | Health Technology |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Schering-Plough Research Institute
Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Health Technology |
The Western Pennsylvania Hospital
 The Western Pennsylvania Hospital Medical/Nursing ServicesHealth Services The Western Pennsylvania Hospital provides clinical and health related services. The hospital offers emergency medicine, heart care, cancer treatment, orthopedics, and surgery services. It is affiliated with Clarion University, Indiana University of Pennsylvania, Pennsylvania State University, and Temple University. The Western Pennsylvania Hospital is founded in 1848 and is headquartered in Pittsburgh, PA. | Health Services |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Ignyta, Inc. operates as a medicine biotechnology company. The firm engages in the discovering, acquiring, developing and commercializing targeted new drugs for cancer patients. The company was founded by Jonathan E. Lim on September 13, 2011 and is headquartered in South San Francisco, CA. | Health Technology |
Polynoma LLC
Polynoma LLC BiotechnologyHealth Technology Part of CK Life Sciences International (Holdings), Inc., Polynoma LLC is an immuno-oncology focused biopharmaceutical company headquartered in San Diego, CA. Polynoma's lead asset is a novel polyvalent antigen vaccine, Seviprotimut-L, for the prevention of recurrence of melanoma. The vaccine has been safely administered in more than 1,000 patients. Polynoma is an immuno-oncology company developing a novel polyvalent antigen therapy for the treatment of melanoma. The company was founded by Paul A. Hopper. | Health Technology |
- Bolsa de valores
- Insiders
- Sara Zaknoen